Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II–III breast cancer [abstract] - Sparano, J A; OʼNeill, A; Alpaugh, K (Cancer Res, 2018)
In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5–9; San Antonio, TX Philadelphia (PA): AACR